SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-011482
Filing Date
2023-02-14
Accepted
2023-02-14 16:00:23
Documents
1
Group Members
JOSEPH REDA C/F ANGUS PATRICK DEENEY UTMA/NYJOSEPH REDA C/F CLAIRE ESTIE DEENEY UTMA/NYJOSEPH REDA C/F DUSTIN RUSSELL REDA UTMA/NYJOSEPH REDA C/F JOSEPH WILLIAM REDA UTMA/NY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea123456-13ga1reda_silo.htm SC 13G/A 102147
  Complete submission text file 0001213900-23-011482.txt   103947
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Subject) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87110 | Film No.: 23628388
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl

Mailing Address 1324 MANOR CIRCLE PELHAM NY 10803
Business Address
Reda Joseph (Filed by) CIK: 0001952100 (see all company filings)

Type: SC 13G/A